The 2017 Market for NGS Informatics: Probing the Commercial Landscape is designed to help companies navigate the crowded market for products and services that support Next Generation Sequencing (NGS) data analysis and storage. Scientists face many challenges when choosing a solution: it is often difficult to determine the significance of results, the storage space needed […]
Market Research
The 2017 Market for NGS Informatics: Probing the Commercial Landscape is designed to help companies understand the challenges NGS users face each day. The scale of the data generated is not simply an obstacle for individual researchers trying to interpret it, but it presents significant informatics issues for reproducibility and even collaboration. NGS users are […]
BioInformatics LLC’s 2017 Market for Research Antibodies: Keys to Success for Commercial Suppliers is a new research report based on a 36-question survey, completed by 1,074 scientists around the world between May 17 and July 4. The primary research report examines scientists’ preferences regarding the purchase and use of antibodies, as well as customer trust, satisfaction […]
Laboratories around the world are generating raw sequencing data at an unprecedented rate. Today it is possible to generate hundreds of millions of relatively short sequences in a single run in a short period of time with low per base cost. These technological developments have enabled widespread adoption of sequencing. At the same time, the […]
The Market for Analytical & Life Science Instrumentation in China: Dispatch from the Middle Kingdom is the latest market research report from BioInformatics LLC and our SDi division. This report was specifically developed to go beneath the surface of the instrumentation market in China to address and explore the engines that drive its growth and to […]
According to China’s FDA (CFDA), the State Council issued two five-year plans on food and drug safety earlier this year that will impact analytical instrument manufacturers. In regards to food safety, violation laws and quality standards will be much stricter, with over 300 national standards for consumer foods, agricultural products and pesticides to be issued […]
In both our 2017 Global Assessment Report: The Analytical and Life Science Instrument Market and our survey of life science lab budgets we reported that Asian markets were growing faster than scientific markets in the US and Europe. Chinese in particular is of great interest to our clients and we will soon be publishing a […]
The market for antibodies currently has a very large number of suppliers. Given the importance of trust in this particular market, it is not surprising that leading suppliers invest heavily in order to develop enduring brand loyalty. In our report, The 2017 Market for Research Antibodies: Keys to Success for Commercial Suppliers, one of the […]
We’ve long known that scientific customers can exhibit remarkable brand loyalty. When we ask what made you choose this product over another, the answer is consistently “It’s what has worked for me in the past” or “It was recommended to me by a colleague.” Such was the case when we last explored the antibody market […]
The 2017 Market for Research Antibodies: Keys to Success for Commercial Suppliers is BioInformatics LLC’s newest report, a comprehensive analysis of this lucrative market. Designed specifically for suppliers of commercial, pre-made catalog antibodies, this primary research report identifies scientists’ expectations and preferences with regards to usage, brands, purchasing, product quality and budgets. For companies competing […]
Pay Invoice
Latest Blogs
-
NAMs Shift from Policy to Practice: What Life Science R&D Suppliers Need to Know in 2026
March 11, 2026 3:51 pm
Sitemap
Your Data and Privacy
About Us
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.

